Here, we review five classes of bioactive components relevant to BC in the context of pediatric use: (1) Igs, (2) LF, lysozyme, and α-lactalbumin, (3) milk fat globule membrane proteins, (4) oligosaccharides, and (5) microRNA and stem cells (Figure 2). This evidence concerns the gene LTF and breast cancer.